mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer - a retrospective review of 92 biopsied PIRADS 3 Lesions

被引：0
|
作者：
Liddell, H. [1 ]
Jyoti, R. [2 ]
Haxhimolla, H. Z. [1 ,3 ]
机构：
[1] Canberra Hosp, Dept Urol, Garran, Australia
[2] Calvary Hosp, Universal Med Imaging, Bruce, Australia
[3] Australian Natl Univ, Acton, Australia
来源：
BJU INTERNATIONAL | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
201
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [1] PIRADS 3 LESIONS CHARACTERISED BY MP-MRI OF THE PROSTATE CORRESPOND WITH AN INTERMEDIATE TO HIGH RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER ON WHOLE SPECIMEN HISTOPATHOLOGY-A RETROSPECTIVE REVIEW OF 42 CASES
    Scott, Susan E.
    Gianduzzo, Troy
    Coughlin, Geoff
    Kua, Boon
    Parkinson, Rob
    Samaratunga, Hemamali
    Yaxley, John
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 59 - 59
  • [2] Factors Predicting Clinically Significant Prostate Cancer on PIRADS 3 lesions
    Lin, J.
    Siddiqui, M.
    Li, E.
    Aguiar, J.
    Ansbro, B.
    Soliman, M.
    Rich, J.
    Alfaro, J.
    Keeter, M.
    Schaeffer, E.
    Ross, A.
    EUROPEAN UROLOGY, 2022, 81 : S701 - S702
  • [3] PREDICTORS OF CLINICALLY SIGNIFICANT PROSTATE CANCER WITH PIRADS CATEGORY 3 MPMRI LESIONS
    Zorawar, Singh
    Karen, Huang
    Derek, Tran
    Manish, Vira
    Simon, Hall
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [4] TITLE: PIRADS 3 RADIOLOGIC "GREY ZONE" - WHAT PROPORTION OF MEN WHO HAVE PIRADS 3 LESIONS REPORTED ON MP-MRI HAVE PROSTATE CANCER?
    Costello, Daniel
    Cathcart, Paul
    Parkin, Cameron
    Frydenberg, Mark
    Moon, Daniel
    Peters, Justin
    El Hage, Oussama
    Challacombe, Ben
    Costello, Anthony
    JOURNAL OF UROLOGY, 2018, 199 (04): : E526 - E526
  • [5] FACTORS PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN PIRADS 4 LESIONS
    Siddiqui, Mohammad
    Lin, Jasmine
    Aguiar, Jonathan
    Ansbro, Brandon
    Soliman, Moataz
    Rich, Jordan
    Alfaro, Johan
    Keeter, Mary-Kate
    Mai, Quan
    Schaeffer, Edward
    Ross, Ashley
    JOURNAL OF UROLOGY, 2022, 207 (05): : E962 - E963
  • [6] ECHOGENICITY ENHANCES RISK ASSESSMENT OF LESIONS ON MP-MRI FOR CLINICALLY SIGNIFICANT PROSTATE CANCER
    Wegner, Garret
    Khan, Amir
    Panagos, Michael
    Wang, Shu
    Van Besien, Alexa J.
    Naslund, Michael
    Siddiqui, Mohummad Minhaj
    JOURNAL OF UROLOGY, 2024, 211 (05): : E302 - E302
  • [7] ULTRASOUND ECHOGENICITY CAN RISK STRATIFY LESIONS ON MP-MRI FOR CLINICALLY SIGNIFICANT PROSTATE CANCER
    Wegner, Garret
    Khan, Amir
    Panagos, Michael
    Wang, Shu
    Van Besien, Alexa J.
    Naslund, Michael James
    Siddiqui, Mohummad Minhaj
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S76 - S76
  • [8] Investigating prostate cancer - the clinical challenge of PIRADS 3 lesions
    Kim, J.
    Mcclintock, S.
    BJU INTERNATIONAL, 2019, 123 : 11 - 12
  • [9] The role of multidisciplinary MRI prostate review meeting in reducing the need for immediate targeted biopsies of prostate imaging reporting and data system (PIRADS) category 3 lesions identified on multiparametric prostate MRI (MP-MRI)
    Choo, Zhen Wei
    Kwok, Jia Lun
    Tan, Teck Wei
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 29 - 29
  • [10] Comparison of the incidence of clinically significant prostate cancer in patients with isolated peripheral versus transitional zone PIRADS 3 lesions
    Malshy, Kamil
    Ochsner, Anna
    Ortiz, Rebecca
    Ahn, Benjamin
    Glebocki, Richard
    Liu, Matthew
    Golijanin, Borivoj
    Eaton, Samuel
    Pareek, Gyan
    Hyams, Elias
    Golijanin, Dragan
    Khaleel, Sari
    UROLOGIA JOURNAL, 2025, 92 (01) : 51 - 58
12345